Overview:
Intravenous solutions present a combination of nutrients that support patients to get essential nutrition. The demand for intravenous solutions on the global front is undergoing steady growth and its market presents a higher growth in Asia-Pacific region. Intravenous products are highly regulated for quality and availability assurance. Though matured, this market has been undergoing continuous evolution, thus experiencing a steady growth.
The intravenous solutions manufacturers and vendors worldwide are perpetually improving the nature of products, and sales and distribution methods respectively. Several large players have employed direct sales force and independent distributors, retail and wholesalers. Alternate modes of supply are also employed by the manufacturers to retain profitability. Third parties that store and deliver products for the manufacturer have a significant foothold in the developed markets. These type of vendors are found to better cater swift customer service as they always stock adequate inventories. Other sales practices in this market include sales through customer and sales service representatives, catalogue circulation and merchandising, electronic purchase facility and allied benefits, e-mail campaign, publicity through trade publications and trade fairs and others.
The global intravenous solutions market is segmented on the following bases:
1. Type
a. Partial Parenteral Nutrition
b. Total Parenteral Nutrition
2. Nutrients
a. Carbohydrates
b. Salts and Electrolytes
c. Minerals
d. Vitamins
e. Amino Acids
3. Geography
a. North America
i. US
ii. Canada
b. Europe
i. UK
ii. Germany
iii. Rest of Europe
c. Asia-Pacific
i. Japan
ii. China
iii. Rest of APAC
d. Latin America
e. Middle East and Africa
Key players identified for intravenous solutions market market include but are not limited to:
Ajinomoto Co., Inc., B. Braun Melsungen AG, Baxter International, Fresenius Kabi, Groupe Danone, Hospira, Inc, Kyowa Hakko Kogyo Co., Ltd., Kelun Pharmaceutical Co., Ltd., Grifols, Otsuka Pharmaceutical Co., Ltd., Terumo Corporation and others
This report offers:
